Powered by Cellarion
Understanding iPSCs and the Future of Regenerative Medicine
Renue is one of only a small number of clinics in the world, alongside Kyoto Hospital, offering Yamanaka-grade induced Pluripotent Stem Cell (iPSC) therapy, through our partnership with Cellarion.
A New Era in Human Longevity
For decades, society accepted aging as an unavoidable decline, a natural, irreversible process written into our DNA. But epigenetic research has now shattered that belief. We now know that aging is not inevitable. It is modifiable, measurable, and increasingly manageable. The same data-driven scientific approach that revolutionized computing, medicine, and biotechnology is now transforming our understanding of cellular health and human longevity.
At the heart of this breakthrough is the discovery that our epigenome, the system that turns genes "on" or "off", can be influenced, optimized, and even reset. Environmental factors, lifestyle, stress, inflammation, and cellular damage all leave measurable marks on our biology. More importantly, these marks can be reversed. Today's leading-edge research shows that by targeting cellular pathways, reducing inflammation, restoring mitochondrial function, and correcting age-related epigenetic drift, we can meaningfully impact how we age, not just how long we live, but how well.
Aging is not fate. It's a process, and processes can be improved. Armed with data, guided by epigenetics, and powered by advanced regenerative medicine, we stand at the threshold of redefining human potential. Not by adding years to life, but by adding life to years.
Demystifying iPSCs
An induced pluripotent stem cell (iPSC) is an adult cell reprogrammed into a stem-cell state. iPSCs are not embryonic stem cells, and the reprogramming process does not alter DNA. It uses Sendai Technology (built on the 2012 Nobel Prize-winning discovery) to safely deliver reprogramming factors without integrating into the cell's genome.
MSCs vs. iPSCs: The Repair vs. Replace Matrix
MSCs: The Builders
- Primary function: Support tissue repair.
- Mechanism: Anti-inflammatory, immunomodulatory, regenerative properties.
- Current status: Important today for osteoarthritis, inflammation, and joint preservation.
iPSCs: The Shapeshifters
- Primary function: Support personalized cellular replacement.
- Mechanism: Pluripotency and cellular reprogramming.
- Future status: Expanding options for total tissue replacement and specialized cell generation.
The iPSC Manufacturing Pipeline
Quality Control Before Banking
Where This Is Headed
Neurological
Parkinson's disease, stroke, ALS, Alzheimer's disease, multiple sclerosis.
Orthopedic
Cartilage regeneration, severe osteoarthritis, ultimate joint preservation.
Systemic / Organs
Cardiac, retinal, and liver degenerative diseases.
Diabetes
Differentiation into pancreatic islet cells (insulin, glucagon).
These are research-stage and expanding treatment areas. Availability depends on individual case review with Renue's medical team.
iPSC technology begins with a simple blood sample and requires the most rigorous quality control in modern medicine. It perfectly complements Renue's long-term vision of transitioning from cellular repair to total cellular replacement. The future of regenerative medicine is being built today.
Frequently Asked Questions
Does the iPSC reprogramming process alter my DNA?
No. The Sendai Technology used to deliver the Yamanaka reprogramming factors (Oct4, Sox2, Klf4, c-Myc) does not integrate into the cell's DNA.
Are iPSCs the same as embryonic stem cells?
No. iPSCs are adult cells reprogrammed into a stem-cell state. They are not sourced from embryos.
Where does the process start?
With a simple blood draw. Peripheral Blood Mononuclear Cells (PBMCs) are isolated, reprogrammed, expanded into colonies, quality-controlled, and banked.
Why Patients Choose Renue
Advanced Cellular Laboratory
On-site cellular manufacturing with rigorous quality control.
World-Class Physicians
Experienced physicians dedicated exclusively to regenerative medicine.
Hyperbaric Oxygen Center
One of the few clinics integrating HBOT into comprehensive protocols.
Personalized Treatment Plans
Every patient receives an individualized treatment strategy based on their condition and goals.
Concierge Medical Experience
Airport transportation, hotel coordination, and dedicated patient support throughout your stay.
Long-Term Follow-Up
Our relationship continues well beyond your visit with structured physician follow-up.
Get started
Ask About iPSC Therapy
Speak with a Renue Patient Advisor about whether iPSC therapy is right for your case.